In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Epitope acquires STC Technologies

Executive Summary

Epitope (oral fluid collection products) will acquire privately held STC Technologies (diagnostic tests and medical devices) in a stock swap that will be accounted for as a tax-free pooling of interests. Epitope will issue 20mm shares valued at $188.2mm, based on the average market price.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Saliva-based Testing
    • Urine-based Testing
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Payment Includes Stock
    • Full Acquisition

Related Companies

UsernamePublicRestriction

Register